The positive expression rate of KAI1/CD82 expression was significantly lower in NSCLC tissues (36.5%, 69/189) than that in the control normal lung tissues (84.7%, 160/189; P <.001; Fig. 1G and 1H). This evidence concerns the gene CD82 and non-small cell lung carcinoma.